C37H46N4O6
Neat
642.80
-20°C
Room Temperature
Lopinavir Metabolite M-1; 192725-39-6; 4-Oxolopinavir; 4-Oxo-lopinavir; Lopinavir Metabolite M1; Lopinavir (m1); FA4KE7HY7K; (2S)-N-[(2S, 4S, 5S)-5-[[2-(2, 6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1, 6-diphenylhexan-2-yl]-2-(2, 4-dioxo-1, 3-diazinan-1-yl)-3-methylbutanamide; Lopinavir impurity E [WHO-IP]; UNII-FA4KE7HY7K; CHEMBL30185; DES(2-oxo-tetrahydropyrimidinyl)-2, 4-dioxo-tetrahydropyrimidinyllopinavir; 1(2H)-Pyrimidineacetamide, N-((1S, 3S, 4S)-4-((2-(2, 6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2, 4-dioxo- and (alphaS)-; Lopinavir M1 metabolite; orb1984684; GLXC-15404; BDBM50099842; AKOS040757133; HY-136703; CS-0133380
(2S)-N-[(2S, 4S, 5S)-5-[[2-(2, 6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1, 6-diphenylhexan-2-yl]-2-(2, 4-dioxo-1 and 3-diazinan-1-yl)-3-methylbutanamide
InChI=1S/C37H46N4O6/c1-24(2)34(41-19-18-32(43)40-37(41)46)36(45)38-29(20-27-14-7-5-8-15-27)22-31(42)30(21-28-16-9-6-10-17-28)39-33(44)23-47-35-25(3)12-11-13-26(35)4/h5-17,24,29-31,34,42H,18-23H2,1-4H3,(H,38,45)(H,39,44)(H,40,43,46)/t29-,30-,31-,34-/m0/s1